Loading...
9 Australia Biologics Reports
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Amgen, Eli Lilly and Company, GlaxoSmithKline, Abbvie, Roche
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Amgen, Biogen, Cipla, Lupin, Pfizer
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: AbbVie Inc, Bristol-Myers Squibb, Pfizer, Novartis, Takeda Pharmaceuticals
Country Covered: Australia
Study Period: 2021 - 2030
Major Players: Sanofi, Stryker, Zimmer Biomet, Seaspine, Medtronic
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Roche, Regeneron Pharmaceuticals, Abbvie, MeiraGTx, Oxurion
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Orthofix, Zimmer Biomet, Arthrex, Johnson & Johnson, Stryker
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Teva Pharmaceutical Industries, Abbvie, Amgen, Johnson & Johnson, Bristol-Myers Squibb
